Statins

This page covers all Statins drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HMG-CoA reductase.

Targets

HMG-CoA reductase

Marketed (1)

• Pitavastin 4mg · University of Kansas Medical Center · Metabolic

Phase 2 pipeline (2)

• Atorvastatin and Dexamethasone · Oriental Neurosurgery Evidence-Based-Study Team · Cardiovascular
  Atorvastatin inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis, while Dexamethasone is a corticosteroid that suppresses inflammation and immune responses.
• LDL reduction therapy · Samsung Medical Center · Cardiovascular
  HMG-CoA reductase inhibitor